Does AI/ML make CROs obsolete? It depends…

The CRO industry has a choice to make: their leaders can retire to a plantation, as the famous pirate Henry Morgan did, or they can adapt their model to one that is technology driven and cost-efficient, leveraging it to deliver clinical trials, says Taimei’s Scott Clark.

Read More

Why data management and decision-making go hand-in-hand in clinical research

The pharmaceutical industry is fuelled by data. Huge amounts of information are available from sources as diverse as patient health records, wearables, and social media content. If sponsors can harness it, this data can provide the key to saving time, labour and costs across the pharmaceutical value chain, ultimately bringing better drug products to patients sooner.

Read More

How automating clinical trial payments can unlock end-to-end efficiencies

Traditional approaches to payment management for clinical trials are highly manual, labour-intensive, and subject to human error. In an industry where timelines are critical and accuracy is paramount, sponsors seek a better way to negotiate, track and reconcile trial payments. Automation takes away the manual burden while offering new levels of speed and accuracy.

Read More